ERBB2 and breast cancer: Finally, immunohistochemical analysis of ATP1A1 protein expression in a breast tissue microarray (TMA) that included 120 specimens of different breast cancer subtypes showed that ATP1A1 was more highly overexpressed in TNBC than in other breast cancer subtypes (Luminal A, B, and HER2+) (Figure 4F).